Xlife Sciences AG (XLS DE): Breakthrough in Drug Development
First available holistic medical drug to treat Covid-19 and flu viruses ZURICH, SWITZERLAND - EQS Newswire - 10 June 2021 - As a project company of Xlife Sciences AG (XLS DE), inflamed pharma GmbH has developed a revolutionary and holistic therapeutic approach to treat both SARS-CoV-2 and flu viruses. The patented active substance ProcCluster (R) reduces the viral load by 90% and acts against infe...
read full article









